Acumen Pharmaceuticals (NASDAQ:ABOS – Free Report) had its price target raised by Citigroup from $4.00 to $5.00 in a report released on Tuesday,Benzinga reports. They currently have a buy rating on the stock. A number of other equities analysts also recently issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares […]

Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) had its price target upped by investment analysts at Citigroup from $4.00 to $5.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s price target would indicate a potential upside of 79.53% from the company’s […]

Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) had its price objective lifted by research analysts at Jefferies Financial Group from $88.00 to $105.00 in a research note issued on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Jefferies Financial Group’s target price would suggest a potential upside of 17.59% from […]